Journal of Translational Medicine (Jun 2024)

New evidence for a role of DANCR in cancers: a comprehensive review

  • Rong Yuan,
  • Zhao-jun Xu,
  • Sheng-kang Zhang,
  • Xian-ya Cao,
  • Ai-guo Dai,
  • Lan Song

DOI
https://doi.org/10.1186/s12967-024-05246-z
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 23

Abstract

Read online

Abstract Cancer remains a leading cause of mortality and poses a substantial threat to public health. Studies have revealed that Long noncoding RNA DANCR is a cytoplasmic lncRNA whose aberrant expression plays a pivotal role in various cancer types. Within tumour biology, DANCR exerts regulatory control over crucial processes such as proliferation, invasion, metastasis, angiogenesis, inflammatory responses, cellular energy metabolism reprogramming, and apoptosis. By acting as a competitive endogenous RNA for miRNAs and by interacting with proteins and mRNAs at the molecular level, DANCR contributes significantly to cancer progression. Elevated DANCR levels have also been linked to heightened resistance to anticancer drugs. Moreover, the detection of circulating DANCR holds promise as a valuable biomarker for aiding in the clinical differentiation of different cancer types. This article offers a comprehensive review and elucidation of the primary functions and molecular mechanisms through which DANCR influences tumours.

Keywords